Kodi Ravichandran, PhD

Medical School Department Pathology and Immunology
Research Program Tumor Immunology
Kodi Ravichandran

Researcher Background

Primary Academic Title

Professor, Department of Pathology & immunology, WashU Medicine

Training

  • 1992 - 1996: Post-Doctoral Fellowship, Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA

Education

  • 1987: B.V.Sc., Madras Veterinary College, Madras, India
  • 1992: PhD, University of Massachusetts, Amherst, MA

Research & Selected Publications

Research Interest

Tumor cells use many ways to evade immune recognition. Our laboratory focuses on how the lipid phosphatidylserine exposed on live tumor cells help misdirect macrophages to create an anti-inflammatory tone within the tumor neighborhood. Targeting this lipid (which is feasible) may help in promoting anti-tumor immunity.

Research Publications

Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced Cardiomyopathy.
Authors:

Guo Z, Ataran A, Ma P, one or more additional authors omitted Ravichandran KS, one or more additional authors omitted Javaheri A

Journal & Year:

Circulation • 2025

CORESH: a gene signature-based search engine for public gene expression datasets.
Authors:

Sukhov V, Nugmanova A, Vorontsov Y, one or more additional authors omitted Ravichandran K, one or more additional authors omitted Sergushichev A

Journal & Year:

Nucleic Acids Res • 2025

Rapid unleashing of macrophage efferocytic capacity via transcriptional pause release.
Authors:

Tufan T, Comertpay G, Villani A, one or more additional authors omitted Ravichandran KS

Journal & Year:

Nature • 2024